🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess peak FEV1 of two doses of QVM149 com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-01-21
Trial ID
NCT03063086
Treatments Being Tested
The purpose of this study is to compare treatment with QVM149, an inhaler t...
Status
Withdrawn
Location
Robarts Research Insitute; The University of Western Ontario; London Health Sciences Centre
Start Date
2021-12-01
Trial ID
NCT04206761
Treatments Being Tested
The purpose of the trial was to evaluate the efficacy and safety of two dif...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-12-08
Trial ID
NCT02571777
Treatments Being Tested
Double-blind, randomized, two-way cross-over study with two treatment perio...
Status
Completed
Location
University Medical Center Groningen
Start Date
2020-09-10
Trial ID
NCT04259164
This surveillance was designed as a prospective, open-label, multicenter, s...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2022-05-09
Trial ID
NCT05274425
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of indacat...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-08-04
Trial ID
NCT05776927
The purpose of this study was to provide long term safety data of QMF149 in...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-04-25
Trial ID
NCT03100500
Treatments Being Tested
The purpose of this trial was to demonstrate that the efficacy of two treat...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-02-05
Trial ID
NCT03158311
Treatments Being Tested
This was a randomized, placebo-controlled, double-blind, six-sequence, thre...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-06-26
Trial ID
NCT03108027
The purpose of this study is to provide long term safety data of QVM149 in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-04-28
Trial ID
NCT03100825
Treatments Being Tested